Skip to main content

Table 3 Change in SF-36 norm based Domain scores in responders among refractory HCV patients re-treated with pegylated interferon alpha 2b and ribavirin

From: Improvement in quality of life measures in patients with refractory hepatitis C, responding to re-treatment with Pegylated interferon alpha -2b and ribavirin

SF-36 domain Change in QOL scores compared to baseline At 48 wks to 24 wks (24 wk-48 wk)
  24 wks 48 wks 72 wks  
Physical Function -5.25* -2.02 1.04 3.23
Role Physical -7.02 -4.87 5.15 2.14
Bodily Pain -3.31 -2.13 1.96 1.18
General Health -4.53* -3.88 1.55 0.65
Vitality -8.28** -8.40^ 5.69 -0.12
Social Functioning -7.33 -5.30 4.87 2.03
Role-Emotional -4.98 -2.42 5.50 2.56
Mental Health -4.32 -3.76 0.10 0.56
Physical Component Score -5.99^^ -3.54 2.26 2.45
Mental Component Score -5.20* -3.48 2.49 1.71
  1. *p = .01 to .05, ** p = .001, ^ p = .003, ^^ p = .007. Negative value suggests a decrease in the QOL domain